Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 221
D
Biographical Notes on Committee Members
STUART H. ALTMAN, dean of the Helter Graduate School for Social
Policy, Brandeis University, and Sol C. Chaikin Professor of National
Health Policy, is in his second term as chairman of the congressionally
legislated Prospective Payment Assessment Commission, which oversees
the Medicare hospital payment system. Between 1971 and 1976, Dean
Altman was deputy assistant secretary for planning and evaluation/health
in the Department of Health, Education, and Welfare. As deputy assistant
secretary, he was one of the principal contributors to the development
and advancement of the administration's national health insurance pro-
posal. From 1973 to 1974, he served as deputy director for health of the
President's Cost-of-Living Council and was responsible for developing
the council's program on health care cost containment. Dean Altman has
testified before various congressional committees on the problems of
rising health care costs and the need to mandate a minimum benefits
package for all full-time workers. He holds a Ph.D. in economics from the
University of California, Los Angeles, and has taught at Brown Univer-
sity and the University of California, Berkeley.
DAVID BALTIMORE is director of the Whitehead Institute for Bio-
medical Research and professor of biology at the Massachusetts Institute
of Technology. From 1974 until 1982, when he was named director of the
institute, he was with the Center for Cancer Research of the Massachu-
setts Institute of Technology. He has taught in the Department of Biology
at the Massachusetts Institute of Technology since being appointed to the
221
OCR for page 222
222 APPENDIX D
faculty in 1968. In 1975 he received the Nobel Prize, together with
Howard Temin and Renato Dulbecco, for the discovery of reverse
transcriptase retroviruses. That same year he was an organizer of the
Asilomar Conference in California, which focused attention on the
development of genetic engineering, and he was later a member of the
National Institutes of Health Recombinant DNA Advisory Committee.
His present research focuses on molecular immunology, virology, AIDS,
and cancer. Dr. Baltimore received his B.A. degree in chemistry from
Swarthmore College and his Ph.D. in biology from Rockefeller Univer-
sity.
THEODORE COOPER is chairman of the board and chief executive
officer of The Upjohn Company, Kalamazoo, Michigan. Prior to joining
Upjohn in 1980, Dr. Cooper was dean of the Cornell University Medical
College. He was appointed to that position in 1977. From 1975 until 1977,
he served as assistant secretary for health in the Department of Health,
Education, and Welfare. Dr. Cooper has also directed the Heart and Lung
Institute of the National Institutes of Health and has held academic
appointments at St. Louis University, the University of New Mexico,
Cornell University Medical College, and Rockefeller University. He is
the author or coauthor of more than 150 scientific papers and is a member
of the American College of Cardiology, the American Physiological
Society, the American Society for Clinical Investigation, and the Amer-
ican Society for Pharmacology and Experimental Therapeutics. Dr.
Cooper is also a member of the Director's Advisory Committee of the
National Institutes of Health, the Army Science Board, and the Advisory
Council on Hazardous Substances Research and Training.
KRISTINE GEBBIE is the administrator of the Oregon Health Division,
a position she has held since 1978. She has taught nursing studies at St.
Louis University and the University of California, Los Angeles, and is an
adjunct associate professor of nursing at the Oregon Health Sciences
University School of Nursing. She is presently a member of the Presi-
dential Commission on the Human Immunodeficiency Virus Epidemic.
Ms. Gebbie is past president of the Association of State and Territorial
Health Officials and chairs the Oregon AIDS Task Force. She received a
B.S. degree in nursing from St. Olaf College, Minnesota, and an M.N. in
community mental health nursing from the University of California
School of Nursing in Los Angeles.
DONALD R. HOPKINS is a senior consultant to Global 2000 Inc. and
the Task Force for Child Survival of the Carter Presidential Center in
Atlanta, Georgia. From 1984 to 1987, he was deputy director of the
OCR for page 223
APPENDIX D 223
Centers for Disease Control; he served as assistant director for interna-
tional health at CDC from 1978 to 1984. Dr. Hopkins taught tropical
public health at the Harvard School of Public Health from 1974 to 1977
and directed the smallpox eradication program in Sierra Leone from 1967
to 1969. He has also authored an authoritative text on the history of
smallpox, Princes and Peasants: Smallpox in History. Dr. Hopkins
received his B.S. degree from Morehouse College, the M.D. degree from
the University of Chicago, an M.P.H. from Harvard University, and an
honorary D.Sc. from Morehouse College. He is a member of the Institute
of Medicine.
KENNETH PREWITT, a political scientist, came to the Rockefeller
Foundation in 1985 from the presidency (1979-1985) of the Social Science
Research Council. From 1965 to 1982 he was a faculty member of the
University of Chicago, becoming chairman of its Department of Political
Science in 1975 and the following year, director of the National Opinion
Research Center. Dr. Prewitt has had extensive first-hand experience in
Africa, first as a visiting lecturer (1965-1966) at the University of East
Africa and Makarere, Uganda, and subsequently (1970-1973) as a Rocke-
feller Foundation Visiting Research Fellow at the University of Nairobi in
Kenya. Dr. Prewitt received his B.A. degree from Southern Methodist
University, an M.A. degree from Washington University, and his Ph.D.
from Stanford University. He is a director of (among other organizations)
the Center for Advanced Study in the Behavioral Sciences at Washington
University and the author or coauthor of a dozen books. He is also a
member of the advisory bodies of several universities, foundations, and
academic councils. Dr. Prewitt is a member of the American Academy of
Arts and Sciences and the recipient of a Guggenheim fellowship.
HOWARD M. TEMIN is American Cancer Society Professor of Viral
Oncology, Harold P. Rusch Professor of Cancer Research, and Steen-
bock Professor of Biological Sciences at the University of Wisconsin
School of Medicine, Madison, where he has been since 1960. He has
worked on retroviruses continuously since 1956, when he was a graduate
student at the California Institute of Technology. In 1975 he received the
Nobel Prize, together with David Baltimore and Renato Dulbecco, for
some of this work. He is a member of the National Academy of Sciences
and has served on the National Institutes of Health Virology Study
Section and on the editorial board of several virology journals. He was
also a member of the committee that wrote Confronting AIDS.
PAUL VOLBERDING is associate professor of medicine at the Univer-
sity of California, San Francisco, and chief of the Medical Oncology
OCR for page 224
224 APPENDIX D
Division and the AIDS Program at San Francisco General Hospital.
During the past several years he has served on a variety of local, national,
and international AIDS committees. He was a member of the steering
committee of the IOM/ NAS panel that wrote Confronting AIDS and is on
the executive committee of the AIDS Clinical Trials Group of the
National Institute of Allergy and Infectious Diseases. Dr. Volberding is
actively involved in the provision of care to AIDS patients and undertakes
clinical research in the treatment of HIV infection and Kaposi's sarcoma.
He received an A.B. degree from the University of Chicago and an M.D.
from the University of Minnesota.
Representative terms from entire chapter:
cancer research
